Research output per year
Research output per year
Personal profile
Research interests
Jianmin Zuo's work focus on Viral and Cancer Immunology,
Immunology of EBV/CMV infection
We study the T/NK cellular immune responses against EBV/CMV infection over the life course.
Immune modulation of Natural Killer (NK) cells in Cancers
We study the immune modulation of NK cells by Cancer and explore the approaches of NK cells based Immunotherapy.
Biography
After PhD training in Beijing China, Jianmin Zuo obtained a research training fellowship from IARC (WHO) to join the EBV immunology group in Birmingham at 2004.
He has been working on viral immunology for more than 20 years in EBV, CMV and recently COVID-19. He also has been studying the immune modulation of Natural Killer (NK) cells in Cancers, including Leukemia and Solid Cancers.
The inspiration is to explore the potential of NK cells based immunotherapy to treat cancers.
Qualifications
PhD in Immunology 2004
Expertise related to UN Sustainable Development Goals
In 2015, UN member states agreed to 17 global Sustainable Development Goals (SDGs) to end poverty, protect the planet and ensure prosperity for all. This person’s work contributes towards the following SDG(s):
Fingerprint
Dive into the research topics where Jianmin Zuo is active. These topic labels come from the works of this person. Together they form a unique fingerprint.
- 1 Similar Profiles
Collaborations and top research areas from the last five years
Recent external collaboration on country/territory level. Dive into details by clicking on the dots or
-
CD70 identifies alloreactive T cells and represents a potential target for prevention and treatment of acute GvHD
Verma, K., Croft, W., Margielewska-Davies, S., Pearce, H., Stephens, C., Diaconescu, D., Bevington, S., Craddock, C., Amel-Kashipaz, R., Zuo, J., Kinsella, F. A. & Moss, P., 19 Jul 2024, (E-pub ahead of print) In: Blood Advances. bloodadvances.2024012909.Research output: Contribution to journal › Article › peer-review
Open AccessFile20 Downloads (Pure) -
Defects in NK cell immunity of pediatric cancer patients revealed by deep immune profiling
Syrimi, E., Khan, N., Murray, P., Willcox, C., Haigh, T., Willcox, B., Masand, N., Bowen, C., Dimakou, D. B., Zuo, J., Barone, S. M., Irish, J. M., Kearns, P. & Taylor, G. S., 28 Aug 2024, (E-pub ahead of print) In: iScience. 110837.Research output: Contribution to journal › Article › peer-review
Open AccessFile12 Downloads (Pure) -
Early inflammatory markers as prognostic indicators following allogeneic stem cell transplantation
Verma, K., Croft, W., Greenwood, D., Stephens, C., Malladi, R., Nunnick, J., Zuo, J., Kinsella, F. A. M. & Moss, P., 3 Jan 2024, In: Frontiers in immunology. 14, 1332777.Research output: Contribution to journal › Article › peer-review
Open AccessFile55 Downloads (Pure) -
Enhancement of Omicron-specific immune responses following bivalent COVID-19 booster vaccination in patients with chronic lymphocytic leukaemia
Roberts, T., Uwenedi, G., Bruton, R., McIlroy, G., Damery, S., Sylla, P., Logan, N., Scott, S., Lau, M., Elzaidi, A., Plass, S., Mallick, S., Spencer, K., Stephens, C., Bentley, C., Pratt, G., Zuo, J., Paneesha, S., Willett, B. & Moss, P. & 1 others, , 25 Jan 2024, In: Blood Cancer Journal. 14, 1, 3 p., 22.Research output: Contribution to journal › Letter › peer-review
Open AccessFile34 Downloads (Pure) -
Neratinib could be effective as monotherapy or in combination with trastuzumab in HER2-low breast cancer cells and organoid models
Arshad, M., Azad, A., Chan, P. Y. K., Vigneswara, V., Feldinger, K., Nafi, S. N. M., Laporte-Maguire, E., De Santo, C., Zuo, J., Shaaban, A. M. & Kong, A., 10 Apr 2024, (E-pub ahead of print) In: British Journal of Cancer.Research output: Contribution to journal › Article › peer-review
Open AccessFile27 Downloads (Pure)
-
The T cell immune response to cytomegalovirus across the adult lifecourse
Moss, P. (Principal Investigator) & Zuo, J. (Co-Investigator)
31/10/18 → 31/10/25
Project: Research
-
COVID-19 Immunity – National Core Study (IMM-NCS) April 2021-March 2022
Moss, P. (Principal Investigator), Pearce, H. (Co-Investigator), Zuo, J. (Co-Investigator) & Parry, H. (Co-Investigator)
1/04/21 → 31/03/23
Project: Research
-
NCS CLL lab work with Paul Moss
Richter, A. (Researcher), Zuo, J. (Researcher), Parry, H. (Researcher), Moss, P. (Principal Investigator) & Cunningham, A. (Researcher)
1/12/20 → 31/03/21
Project: Research Councils
-
VINCI - Vaccine Immunity in Cancer Patients
Moss, P. (Principal Investigator), Parry, H. (Researcher) & Zuo, J. (Researcher)
1/10/20 → 31/03/21
Project: Research Councils
-
VIVALDI Immune Phenotyping Study
Moss, P. (Principal Investigator) & Zuo, J. (Researcher)
DEPARTMENT OF HEALTH & SOCIAL CARE
2/09/20 → 31/03/23
Project: Other Government Departments